These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 15712608)
21. Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes. Méndez CC; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E Med Mycol; 2008 Mar; 46(2):119-23. PubMed ID: 18324490 [TBL] [Abstract][Full Text] [Related]
22. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes. Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937 [TBL] [Abstract][Full Text] [Related]
25. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Gupta AK; Kohli Y; Batra R Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561 [TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. Jessup CJ; Warner J; Isham N; Hasan I; Ghannoum MA J Clin Microbiol; 2000 Jan; 38(1):341-4. PubMed ID: 10618112 [TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of a soil isolate of Pseudomonas chlororaphis against medically important dermatophytes and identification of a phenazine-like compound as its bioactive metabolite. Ranjbariyan A; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M J Mycol Med; 2014 Jun; 24(2):e57-64. PubMed ID: 24746720 [TBL] [Abstract][Full Text] [Related]
28. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes. Shehata AS; Mukherjee PK; Ghannoum MA J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129 [TBL] [Abstract][Full Text] [Related]
29. Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods. Mota CR; Miranda KC; Lemos Jde A; Costa CR; Hasimoto e Souza LK; Passos XS; Meneses e Silva H; Silva Mdo R Rev Soc Bras Med Trop; 2009; 42(3):250-4. PubMed ID: 19684970 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique. Butty P; Lebecq JC; Mallié M; Bastide JM J Med Vet Mycol; 1995; 33(6):403-9. PubMed ID: 8683409 [TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods. Karaca N; Koç AN Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile]. Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211 [TBL] [Abstract][Full Text] [Related]
33. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers. Kermani F; Javidnia J; Hedayati MT; Abastabar M; Haghani I; Didehdar M; Fami Zaghrami M; Shokohi T Mycoses; 2020 Dec; 63(12):1321-1330. PubMed ID: 32854165 [TBL] [Abstract][Full Text] [Related]
34. An evaluation of the in vitro activity of terbinafine. Jessup CJ; Ryder NS; Ghannoum MA Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232 [TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran. Sharifzadeh A; Shokri H; Khosravi AR Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045 [TBL] [Abstract][Full Text] [Related]
36. Antidermatophytic activity of allylamine derivatives. Venugopal PV; Venugopal TV Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170 [TBL] [Abstract][Full Text] [Related]
37. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium. Sarifakioglu E; Seçkin D; Demirbilek M; Can F Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532 [TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of lichen compounds against dermatophytes: a review. Furmanek Ł; Czarnota P; Seaward MRD J Appl Microbiol; 2019 Aug; 127(2):308-325. PubMed ID: 30664814 [TBL] [Abstract][Full Text] [Related]
39. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389 [TBL] [Abstract][Full Text] [Related]
40. A study of dermatophytes and their in-vitro antifungal sensitivity. Sumana MN; Rajagopal V Indian J Pathol Microbiol; 2002 Apr; 45(2):169-72. PubMed ID: 12696733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]